valsartan has been researched along with Constriction, Pathological in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Q; Hu, Z; Liu, C; Pan, C; Ren, X; Yu, YH; Zhao, L | 1 |
| Crane, JA; Ebrahimi, B; Eirin, A; Jordan, KL; Krier, JD; Lerman, A; Lerman, LO; Li, ZL; Pawar, AS; Tang, H; Textor, SC; Zhang, X; Zhu, XY | 1 |
| Horiuchi, M; Ide, A; Ito, M; Iwai, M; Mogi, M; Okumura, M | 1 |
| Egashira, K; Funakoshi, K; Ihara, Y; Nakano, K; Ohtani, K; Sata, M; Sunagawa, K; Zhao, G | 1 |
4 other study(ies) available for valsartan and Constriction, Pathological
| Article | Year |
|---|---|
LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Improves Cardiac Hypertrophy and Fibrosis and Cardiac Lymphatic Remodeling in Transverse Aortic Constriction Model Mice.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Aortic Diseases; Biphenyl Compounds; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Drug Combinations; Fibrosis; Male; Mice; Neprilysin; Receptors, Angiotensin; Tetrazoles; Valsartan | 2020 |
Angiotensin receptor blockade has protective effects on the poststenotic porcine kidney.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Animals; Constriction, Pathologic; Disease Models, Animal; Female; Glomerular Filtration Rate; Hemodynamics; Kidney; Microcirculation; Oxidative Stress; Receptors, Angiotensin; Renal Artery Obstruction; Swine; Tetrazoles; Valine; Valsartan | 2013 |
Sex difference in vascular injury and the vasoprotective effect of valsartan are related to differential AT2 receptor expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Constriction, Pathologic; Dose-Response Relationship, Drug; Female; Femoral Artery; Male; Mice; Mice, Knockout; Oxidative Stress; Receptor, Angiotensin, Type 2; Sex Characteristics; Tetrazoles; Valine; Valsartan; Vasculitis; Wounds and Injuries | 2005 |
Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Biomarkers; Blood Pressure; Blood Vessels; Cell Differentiation; Constriction, Pathologic; Iliac Artery; Imidazoles; Inflammation; Inflammation Mediators; Isoenzymes; Macaca fascicularis; Male; Monocytes; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Rabbits; Recurrence; Renin-Angiotensin System; Stem Cells; Stents; Tetrazoles; Tunica Intima; Valine; Valsartan | 2006 |